The effects on muscle fasciculations and ease of tracheal intubation of pretreatment with fazadinium before administration of succinylcholine were evaluated in 85 patients. Four dose levels of fazadinium evaluated were 0.05mg-kg -t, 0.075mg. kg -j, 0.10 mg-kg -~ and 0.15 rag. kg -t . The 0.05 rag. kg-t dose did not always prevent succinylcholine-induced muscle fasciculations. The 0.15 rag. kg -t dose gave poor conditions for tracheal intubation and was therefore discontinued. The 0.075 mg. kg -t dose seemcd optimal.
nylcholine produces very satisfactory muscle relaxation for tracheal intubation. However, its administration often produces muscle fasciculations before muscle relaxation. These muscle fasciculations are thought to be responsible for the undesirable increases in intragastric t and intra-ocular 2 pressures as well as the hyperkalaemia 3 and post-operative muscle pains 4.s that have been reported following succinylcholine administration. Previous investigators have reported that small subparalysing doses of nondepolarising muscle relaxants such as d-tubocurarine, gallamine and pancuronium can attenuate or prevent these undesirable effects if given before administration of succinylcholine. ~- 8 The aim of this study is to establish whether pre-t,eatment with fazadinium, a new nondepolarising muscle relaxant, will prevent succinylcholine fasciculations and, if so, to determine the minimum dose level of fazadinium that consistently achieves this result.
MATERIALS AND METHODS
Eight-five Nigerian patients (ASA physical status 1 or 2) scheduled for elective surgery were studied. The patients gave informed consent. There were 40 males and 45 females. Their ages ranged between 20 and 65 years while their weights were between 60kg and 75 kg. Fifty-five C.E. Famewo, M.B., B.S. Dip. Anaes. (Toronto), F.R.C.P(C), Consultant Anaesthetist, College of Medicine, University of Ibadan, University College Hospital, lbadan. Nigeria. patients were premedicated with intramuscular meperidine ling. kg -I one hour before anaesthetic induction, while the remaining 30 patients were not premedicated. All patients received atropine 0.6rag intravenously at the time of induction of anaesthesia. Anaesthesia was induced in each patient with a sleep dose of thiopentone, followed by administration of succinylcholine bromide 40 mg intravenously. Four dose levels of fazadinium were investigated. Group I: 0.005mg. kg-~; Group 2: 0.075rag. kg-t; Group 3: 0.10mg. kg -I and Group 4:0.15 rag. kg -~. Patients received these different dose levels in a random fashion. The doses were given about three minutes before induction of anaesthesia and succinylcholine administration in each instance. Twenty-five patients were assigned to each dose level. However, only 10 patients received the 0.15mg-kg -~ dose, because this dose level was discontinued due to the poor muscle relaxation obtained after succinylcholine administration. Twenty-five patients were studied at each of the other dose levels of 0. 
RESULTS
None of the patients pretreated with fazadinium at the dose levels between 0.075 rag. kg -t and 0.15 mg. kg -t showed muscle fasciculations. However, fasciculations were observed in 64 per cent of the patients who received the 0.05 mg. kg-; dose (Table 1) . This difference between pre-treated and untreated patients is statistically significant (p < 0.0 i). A reduction in the degree of muscle relaxation produced by succinylcholine was evident following pre-treatment with fazadinium. This was most marked at the 0.15 mg. kg -~ Most of the patients complained of pain at the site of injection during administration of fazadinium. The pain was usually transient and could be minimized by rapid flushing with intravenous infusion. Many of the patients stated that they felt "drowsy" or "dizzy" following the administration of these subparalysing doses of fazadinium in the conscious state.
DISCUSSION
Previous investigations have shown that fazadinium in doses between 1,0mg-kg -t and 1.5 mg-kg -t give quick and satisfactory conditons for tracheal intubation, t~ Fazadinium can therefore be used as an alternative to succinylcholine in situations where the undesirable sideeffects of succinylcholine are best avoided. However, the longer duration of effect (40 to 60 minutes) of fazadinium as compared with succinylcholine (3 to 5 minutes) makes fazadinium unsuitable for very short procedures where relaxation is needed only for tracheal intubation and spontaneous respiration is intended during the maintenance of anaesthesia. In such cases, pretreatment with a small dose of fazadinium allows succinylcholine to be used with greater safety.
The results in this study indicate that doses of fazadinium between 0.075mg.kg -~ and 0.15 mg-kg -~ effectively prevent fasciculations induced by succinylcholine, while the 0.05 mg-kg-; dose was not always effective. Poorer scores for the ease of tracheal intubation were obtained when the 0.15 rag-kg -~ dose of fazadinium was used (Table II) and patients sometimes made gross movement of their limbs when intubation was attempted; hence the abandonment of this dose level at an early stage of the study. No patient however had any recall post-operatively. The dose of 0.15 rag. kg -~ is therefore not recommended because of the unacceptably poor conditions for intubation. When the results were analysed with respect to administration of meperidine and the occurrence of muscle fasciculations, no relation could be established, indicating that premedication with meperidine did not influence the occurrence of succinylcholineinduced fasciculations.
The dose of 40 mg of succinylcholine bromide used in this study is between 0.53 mg. kg -~ and 0.66 mg. kg -~ body weight, representing only 10 per cent maximum variation from the commonly used standard dose of 0.6 rag. kg -I.
The pain experienced by most of the patients during injection of fazadinium is probably due to local irritant effect on the vessel. The feeling of drowsiness expressed by some of the patients in this study has also been reported by Dery tz in a group of conscious patients pretreated with curare. It is possible that this feeling of drowsiness is due to muscle weakness and lid-drooping caused by the sub-paralysing dose of fazadinium rather than to true sedation.
Of the four dose levels investigated, the 0.05 mg. kg -] dose level failed to prevent fasciculations in 64 percent of patients while the 0.15 rag-kg -t dose gave less than favourable conditions for intubation in 90 percent of patients. Whereas both the 0.075mg. kg -t and the 0.10 mg. kg-t doses completely abolished muscle fasciculations, excellent conditions for tracheal intubation (Lund and Stovner grade 3) were more frequent with the 0.075 mg-kg-~ dose (40 per cent of patients) as compared with the 0.10mg. kg -t dose (16 percent of patients). The 0.075 mg. kg dose therefore appears to be optimal in terms of abolishing muscle fasciculations with the least compromise of muscle relaxation for tracheal intubation. If the 0.10mg. kg -] dose is used, a larger dose of succinylcholine 0.9 mg-kg -t will be desirable to ensure better relaxation. Similar antagonism to relaxation produced by succinylcholine has been reported following pretreatment with d-tubocurarine, pancuronium, and gallamine ~3-~s. Consequently, some investigators have recommended larger doses of succinylcholine to achieve satisfactory muscle relaxation following pretreatment with these non-depolarising muscle relaxants. ~6 '17 In conclusion, pretreatment with fazadinium can prevent fasciculations induccd by succinylcholine. The minimal effective dose with least compromise of the ease of intubation is 0.075 mg. kg -~. Pretreatment with fazadinium is recommended to prevent succinylcholine-induced fasciculations and the associated complications, ACKNOWLEDGEMENT I wish to thank Mr. Taiye Ogunsanya of the Department of Anaesthesia, College of Medicine, University College Hospital, lb~dan for his expert secretarial assistance.
